On July 31, we discussed Moderna, one of the two big C-19 vaccine manufacturers. We discussed two situations: earnings and the longer-term trend. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Tags:#mRNA Share: Mark W. Guthner, CFA Previous Post Microstrategy Update: MSTRNext PostNVIDIA: NVDA You Might Also Like Trade Update UUP & TSLA March 10, 2020 Microstrategy Inc: MSTR November 25, 2023 Biogen:BIIB January 23, 2025
You Might Also Like Trade Update UUP & TSLA March 10, 2020 Microstrategy Inc: MSTR November 25, 2023 Biogen:BIIB January 23, 2025
